A phase II trial of lenalidomide for patients with AL amyloidosis

Vaishali Sanchorawala,Daniel G. Wright,M Rosenzweig,Kathleen T. Finn,Martha Skinner,David C. Seldin

A phase II trial of lenalidomide for patients with AL amyloidosis

2006

Vaishali Sanchorawala
Daniel G. Wright
M Rosenzweig
Kathleen T. Finn
Martha Skinner
David C. Seldin

7524 Introduction: A phase II trial was designed to evaluate the toxicity and response rate of lenalidomide (Revlimid, CC-5013), alone and in combination with dexamethasone in patients with AL amyl...

Keywords:

AL amyloidosis
Lenalidomide
Cancer research
Medicine
Oncology
Pathology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations